Search articles in Pharma Appointments

Filter Articles

Open filters

Sections

Found 1,274 articles

Servier Executive Committee appointments
- 17 Apr 2024
- Editor
Previously Head of the Group Transformation & Programs Office, Charlotte Marmousez-Tartar is promoted to the position of Executive Vice President, Corporate Strategy and Transformation. She joined the Executive Committee on February 1, 2024, succeeding Siham Imani.
Sciensus appoints Hugues Hervouet as its Chief Technology Officer
- 17 Apr 2024
- Editor
Hugues Hervouet has been appointed as Sciensus’ Chief Technology Officer. Hugues joins Sciensus having recently served as Senior Vice President and Chief Information Officer at Shutterstock, a leading global technology provider offering high-quality digital content, tools and services.
Martin Meeson, former CEO of Fujifilm Diosynth Biotechnologies succeeds Sylke Hassel following the integration of Novasep
- 17 Apr 2024
- Editor
Axplora, a leading partner to Pharma companies and Biotechs for complex APIs, is pleased to announce the appointment of Martin Meeson as its new Chief Executive Officer (CEO).
Viatris Appoints Corinne Le Goff as Chief Commercial Officer
- 16 Apr 2024
- Editor
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that Corinne Le Goff has joined the company as Chief Commercial Officer and will become a member of the company's Executive Leadership Team, effective today.
Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg invests in AlzeCure and is proposed for election to its board
- 10 Apr 2024
- Editor
AlzeCure Pharma AB (”AlzeCure” or ”the Company”), a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer's disease and pain, today announced that Professor Jan Lundberg invests in the company and is proposed as a new member of the company's board of directors.
Cambridge Cognition strengthens senior management team to deliver growth
- 10 Apr 2024
- Editor
Cambridge Cognition, a leader in digital health solutions for brain health assessment, has announced the appointments of Alex Livingstone-Learmonth as Chief Commercial Officer and Annabelle Miles as Head of Marketing.
Qnovia, Inc. Announces the Appointment of Four New Members to its Scientific Advisory Board
- 10 Apr 2024
- Editor
Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxTM, today announced the appointment of four new members to its Scientific Advisory Board (SAB).
Opthea Appoints Sujal Shah to the Board of Directors
- 4 Apr 2024
- Editor
Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced the appointment of Sujal Shah to the Company’s Board of Directors (the “Board”), effective April 4, 2024.
ICON Announces CFO Transition
- 4 Apr 2024
- Editor
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Chief Financial Officer, Brendan Brennan, will leave his role at ICON in quarter four this year for a new opportunity outside of the CRO industry.
Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human Resources Officer
- 28 Mar 2024
- Editor
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to announce the appointment of Lucie Larguier as Chief Financial Officer (CFO), effective immediately.
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
- 26 Mar 2024
- PharmiWeb Editor
Laverock Therapeutics, a gene-silencing company with a uniquely powerful technology for the development of programmable advanced therapies to tackle major diseases, today announces the appointment of Ali Elsley as Finance Director.
Global Life Science Agency Appoints Chief Financial Officer
- 20 Mar 2024
- PharmiWeb Editor
International specialist marketing and commercial growth agency, ramarketing has announced a senior leadership appointment as it continues to expand globally.
Seqera appoints Melinda Pautsch as Chief Revenue Officer
- 20 Mar 2024
- PharmiWeb Editor
Seqera, the leading software provider for data analysis in the life sciences space, today announced the appointment of Melinda Pautsch as its Chief Revenue Officer (CRO). The appointment marks a significant step in the company's growth journey, as it focuses on strengthening its market position as the open science platform of choice and delivering value for customers across the Nextflow ecosystem.
Bristol Myers Squibb announces the appointment of Guy Oliver as General Manager for the UK and Ireland
- 12 Mar 2024
- PharmiWeb Editor
Bristol Myers Squibb today announced the appointment of Guy Oliver as General Manager for the company in the UK and Ireland.
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
- 8 Mar 2024
- Editor
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that Cristin Hubbard has been named executive vice president and chief commercial officer. Ms. Hubbard will assume responsibility for the company's global commercial operations, effective May 20, succeeding Jeff Ajer.
Zenas BioPharma Appoints Patricia Allen to its Board of Directors
- 7 Mar 2024
- Editor
Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology-directed therapies, today announced the appointment of Patricia Allen to its Board of Directors, on which she also will serve as Chairperson of the Audit Committee.
iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
- 6 Mar 2024
- PharmiWeb Editor
iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced the appointment of Jill DeSimone to its Board of Directors...
CurifyLabs announces Jamie Campbell as New Board Chair to Further Boost Growth and Expansion
- 29 Feb 2024
- Editor
CurifyLabs, a leading health technology company providing automated solutions for producing personalized medicine, announces today the appointment of Jamie Campbell as the new Chair of the Board. This strategic appointment further strengthens CurifyLabs' position as the company continues growth in Europe and expansion to the North American market.
Bionical Solutions Appoints Chief Technology Officer to Create Innovative Data Products and Software for the Digital Business
- 29 Feb 2024
- Editor
Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, today announced the appointment of Andrew Seward as Chief Technology Officer for the Digital business.
BC Platforms Announces Executive Leadership Changes
- 29 Feb 2024
- Editor
BC Platforms AG (hereafter "BC Platforms") today announces that Tero Silvola, current CEO, is leaving the company, effective today. A new Executive office has been formed with current COO, Mikaela Bruhammar, appointed as interim CEO, together with CFO Kaj Työppönen.